title: A denileukin diftitox (Ontak) associated retinopathy?
authors.forename: J B
authors.initials: JB
authors.lastname: Ruddle
authors.forename: C A
authors.initials: CA
authors.lastname: Harper
authors.forename: D
authors.initials: D
authors.lastname: Hönemann
authors.forename: J F
authors.initials: JF
authors.lastname: Seymour
authors.forename: H M
authors.initials: HM
authors.lastname: Prince
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D004167:Diphtheria Toxin / Q000009:adverse effects*; D019337:Hematologic Neoplasms / Q000188:drug therapy; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000009:adverse effects; D012164:Retinal Diseases / Q000139:chemically induced*; D014786:Vision Disorders / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox